Sponsored Links

GeoVax Trial Results Establish A New Benchmark For Preventative HIV Vaccine Model PDF Print E-mail
Medical News - Clinical Trials and Drug Trials
GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX) announced the publication of the results of preclinical testing of a simian prototype of its 2nd generation HIV/AIDS vaccine...

Read more: Clinical Trials / Drug Trials News From Medical News Today